171 related articles for article (PubMed ID: 31808344)
1. Porphyrinoid-Cyclodextrin Assemblies in Biomedical Research: An Update.
Mavridis IM; Yannakopoulou K
J Med Chem; 2020 Apr; 63(7):3391-3424. PubMed ID: 31808344
[TBL] [Abstract][Full Text] [Related]
2. Enhanced photodynamic therapy through supramolecular photosensitizers with an adamantyl-functionalized porphyrin and a cyclodextrin dimer.
Xia L; Wu J; Huang B; Gao Y; Tian J; Zhang W
Chem Commun (Camb); 2020 Sep; 56(75):11134-11137. PubMed ID: 32815939
[TBL] [Abstract][Full Text] [Related]
3. Linear Alternating Supramolecular Photosensitizer for Enhanced Photodynamic Therapy.
Tian J; Xia L; Wu J; Huang B; Cao H; Zhang W
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32352-32359. PubMed ID: 32584539
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembled Porphyrinoids: One-Component Nanostructured Photomedicines.
Paramio I; Torres T; de la Torre G
ChemMedChem; 2021 Aug; 16(16):2441-2451. PubMed ID: 33900022
[TBL] [Abstract][Full Text] [Related]
5. The application of antimicrobial photodynamic therapy on S. aureus and E. coli using porphyrin photosensitizers bound to cyclodextrin.
Hanakova A; Bogdanova K; Tomankova K; Pizova K; Malohlava J; Binder S; Bajgar R; Langova K; Kolar M; Mosinger J; Kolarova H
Microbiol Res; 2014; 169(2-3):163-70. PubMed ID: 23899404
[TBL] [Abstract][Full Text] [Related]
6. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
[TBL] [Abstract][Full Text] [Related]
7. Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria.
Sobotta L; Skupin-Mrugalska P; Piskorz J; Mielcarek J
Eur J Med Chem; 2019 Aug; 175():72-106. PubMed ID: 31096157
[TBL] [Abstract][Full Text] [Related]
8. Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management.
Almeida-Marrero V; van de Winckel E; Anaya-Plaza E; Torres T; de la Escosura A
Chem Soc Rev; 2018 Oct; 47(19):7369-7400. PubMed ID: 30152500
[TBL] [Abstract][Full Text] [Related]
9. Porphyrins in photodynamic therapy - a search for ideal photosensitizers.
Pushpan SK; Venkatraman S; Anand VG; Sankar J; Parmeswaran D; Ganesan S; Chandrashekar TK
Curr Med Chem Anticancer Agents; 2002 Mar; 2(2):187-207. PubMed ID: 12678743
[TBL] [Abstract][Full Text] [Related]
10. Porphyrin-Based Metal-Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy.
Yu W; Zhen W; Zhang Q; Li Y; Luo H; He J; Liu Y
ChemMedChem; 2020 Oct; 15(19):1766-1775. PubMed ID: 32715651
[TBL] [Abstract][Full Text] [Related]
11. Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.
Ben Mihoub A; Larue L; Moussaron A; Youssef Z; Colombeau L; Baros F; Frochot C; Vanderesse R; Acherar S
Molecules; 2018 Aug; 23(8):. PubMed ID: 30072672
[TBL] [Abstract][Full Text] [Related]
12. Current status of liposomal porphyrinoid photosensitizers.
Skupin-Mrugalska P; Piskorz J; Goslinski T; Mielcarek J; Konopka K; Düzgüneş N
Drug Discov Today; 2013 Aug; 18(15-16):776-84. PubMed ID: 23591149
[TBL] [Abstract][Full Text] [Related]
13. Bacteriochlorophyll a, and its derivatives: chemistry and perspectives for cancer therapy.
Grin MC; Capital Em Cyrillicironov CA; Shtil AC
Anticancer Agents Med Chem; 2008 Aug; 8(6):683-97. PubMed ID: 18690829
[TBL] [Abstract][Full Text] [Related]
14. Inclusion complex vs. conjugation of hydrophobic photosensitizers with β-cyclodextrin: Improved disaggregation and photodynamic therapy efficacy against glioblastoma cells.
Ben Mihoub A; Youssef Z; Colombeau L; Jouan-Hureaux V; Arnoux P; Frochot C; Vanderesse R; Acherar S
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110604. PubMed ID: 32228929
[TBL] [Abstract][Full Text] [Related]
15. Some activities of PorphyChem illustrated by the applications of porphyrinoids in PDT, PIT and PDI.
Habermeyer B; Guilard R
Photochem Photobiol Sci; 2018 Nov; 17(11):1675-1690. PubMed ID: 30109347
[TBL] [Abstract][Full Text] [Related]
16. Fluorinated porphyrinoids as efficient platforms for new photonic materials, sensors, and therapeutics.
Bhupathiraju NVSDK; Rizvi W; Batteas JD; Drain CM
Org Biomol Chem; 2016 Jan; 14(2):389-408. PubMed ID: 26514229
[TBL] [Abstract][Full Text] [Related]
17. The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy.
Rogers L; Senge MO
Future Med Chem; 2014 May; 6(7):775-92. PubMed ID: 24941872
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy.
Otvagin VF; Kuzmina NS; Kudriashova ES; Nyuchev AV; Gavryushin AE; Fedorov AY
J Med Chem; 2022 Feb; 65(3):1695-1734. PubMed ID: 35050607
[TBL] [Abstract][Full Text] [Related]
19. Combination of PDT photosensitizers with NO photodononors.
Fraix A; Sortino S
Photochem Photobiol Sci; 2018 Nov; 17(11):1709-1727. PubMed ID: 30141820
[TBL] [Abstract][Full Text] [Related]
20. Application of TD-DFT Theory to Studying Porphyrinoid-Based Photosensitizers for Photodynamic Therapy: A Review.
Drzewiecka-Matuszek A; Rutkowska-Zbik D
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
